Women + 40 Greens
Testo originale in francese.
Prodotto naturale per la salute autorizzato in Canada
Se questo prodotto fosse venduto in Francia
- Conditions légales
Trifolium pratense L.: La portion journalière recommandée ne doit pas conduire à une ingestion d'isoflavones supérieure à 1 mg/kg de poids corporel (exprimés comme aglycone du composant principal). L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
arrêté du 24 juin 2014, annexe I. Decreti francesi del 9 maggio 2006 (nutrienti), del 24 giugno 2014 (piante) e del 26 settembre 2016 (altre sostanze), raccolta LEGI consolidata, consultato il 23 ottobre 2026.
- Conditions légales
Brassica oleracea L.: L'étiquetage doit comporter un avertissement recommandant aux personnes ayant une hypothyroïdie ou un traitement de la thyroïde de consulter leur médecin.
arrêté du 24 juin 2014, annexe I. Decreti francesi del 9 maggio 2006 (nutrienti), del 24 giugno 2014 (piante) e del 26 settembre 2016 (altre sostanze), raccolta LEGI consolidata, consultato il 23 ottobre 2026.
Si calcola una quantità giornaliera solo per una posologia orale esplicita per adulti, espressa al giorno e in un’unità solida corrispondente alla forma del prodotto. Unità ambigue, liquidi, polveri e dosi pediatriche non vengono estrapolati. Una quantità non calcolata non viene confrontata con i limiti di dose. Questa analisi non costituisce un’autorizzazione alla vendita in Francia né una valutazione di sicurezza o efficacia.
Composizione
| Ingrediente medicinale e fonte | Per unità posologica, secondo la fonte | Massimo giornaliero, adulto |
|---|---|---|
| Beta-D-Fructofuranosidase Fonte : Aspergillus niger Potenza : 125 FCC SU Invertase | 12,5 mg | Non calcolata |
| Beta-D-Fructofuranosidase Fonte : Isolat Potenza : 125 FCC SU Invertase | 12,5 mg | Non calcolata |
| 1,4-alpha-D-Glucane glucohydrolase Fonte : Isolat Potenza : 2,5 FCC AGU Glucoamylase | 5,6 mg | Non calcolata |
| 1,4-alpha-D-Glucane glucohydrolase Fonte : Aspergillus niger Potenza : 2,5 FCC AGU Glucoamylase | 5,6 mg | Non calcolata |
| Taraxacum officinale Fonte : Racine | 12 mg | Non calcolata |
| chlorophylle Fonte : alfalfa | 5 mg | Non calcolata |
| Vaccinium macrocarpon Fonte : Fruit | 4 mg | Non calcolata |
| Lécithine Fonte : Huile de soja | 1.700 mg | Non calcolata |
| 1,5-alpha-L-arabinane arabinanohydrolase Fonte : Isolat Potenza : 450 FCC HCU | 5 mg | Non calcolata |
| 1,5-alpha-L-arabinane arabinanohydrolase Fonte : Aspergillus niger Potenza : 450 FCC HCU | 5 mg | Non calcolata |
| 3-(1-3,1-4)-bêta-D-glucan 3(4)-glucanohydrolase Fonte : Isolat Potenza : 2 FCC BGU | 5 mg | Non calcolata |
| 3-(1-3,1-4)-bêta-D-glucan 3(4)-glucanohydrolase Fonte : Aspergillus niger Potenza : 2 FCC BGU | 5 mg | Non calcolata |
| Lactobacillus delbrueckii subsp. bulgaricus Fonte : Lactobacillus delbrueckii subsp. Bulgaricus Potenza : 0,125 Milliards d'UFC | 2,5 mg | Non calcolata |
| Lactobacillus delbrueckii subsp. bulgaricus Fonte : ATCC SD5589 Potenza : 0,125 Milliards d'UFC | 2,5 mg | Non calcolata |
| Lactobacillus rhamnosus Fonte : Lactobacillus rhamnosus Potenza : 1 Milliards d'UFC | 5 mg | Non calcolata |
| Lactobacillus rhamnosus Fonte : ATCC SD5217 Potenza : 1 Milliards d'UFC | 5 mg | Non calcolata |
| Beta vulgaris Fonte : Racine | 2 mg | Non calcolata |
| Astragalus membranaceus Fonte : Racine | 5 mg | Non calcolata |
| Citrus limon Fonte : Pelure (fruit) | 38 mg | Non calcolata |
| Vaccinium corymbosum Fonte : Fruit | 2 mg | Non calcolata |
| Vitis vinifera Fonte : Graine(s) Potenza : 8,5 mg OPC's | 10 mg | Non calcolata |
| Carica papaya Fonte : Fruit | 2 mg | Non calcolata |
| Trifolium pratense Fonte : Fleur | 15 mg | Non calcolata |
| Withania somnifera Fonte : Racine | 26 mg | Non calcolata |
| Hordeum vulgare Fonte : Plante | 2.115 mg | Non calcolata |
| Hordeum vulgare Fonte : En entier | 2.115 mg | Non calcolata |
| Brassica oleracea var. italica Fonte : Plante entière | 133 mg | Non calcolata |
| 4-(1,3;1,4)-bêta-D-glucane 4-glucanohydrolase Fonte : Aspergillus oryzae Potenza : 315 FCC CU | 7,9 mg | Non calcolata |
| 4-(1,3;1,4)-bêta-D-glucane 4-glucanohydrolase Fonte : Isolat Potenza : 315 FCC CU | 7,9 mg | Non calcolata |
| Curcuma longa Fonte : Racine | 20 mg | Non calcolata |
| Cinnamomum burmannii Fonte : Écorce | 10 mg | Non calcolata |
| Protéase fongique Fonte : Aspergillus niger Potenza : 1.250 FCC HUT | 12,5 mg | Non calcolata |
| Protéase fongique Fonte : Isolat Potenza : 1.250 FCC HUT | 12,5 mg | Non calcolata |
| Bifidobacterium bifidum Fonte : ATCC SD5215 Potenza : 0,25 Milliards d'UFC | 0,5 mg | Non calcolata |
| Bifidobacterium bifidum Fonte : Bifidobacterium bifidum Potenza : 0,25 Milliards d'UFC | 0,5 mg | Non calcolata |
| Pinus strobus Fonte : Écorce | 10 mg | Non calcolata |
| Pectin pectylhydrolase Fonte : Isolat Potenza : 10 Endo-PG Pectinase | 6,4 mg | Non calcolata |
| Pectin pectylhydrolase Fonte : Aspergillus niger Potenza : 10 Endo-PG Pectinase | 6,4 mg | Non calcolata |
| papaïne Fonte : Carica papaya Potenza : 1.296.000 USP units Papain | 54 mg | Non calcolata |
| Lactobacillus acidophilus Fonte : Lactobacillus acidophilus Potenza : 1,5 Milliards d'UFC | 11,25 mg | Non calcolata |
| Lactobacillus acidophilus Fonte : ATCC SD5212 Potenza : 1,5 Milliards d'UFC | 11,25 mg | Non calcolata |
Ingredienti non medicinali
Feuille de persil, Saveur de feuille de Brassica oleracea var. capitata, Vanille (de Tahiti), Pomme, Fraise, épinard, tomate, Poudre de racine de carotte, Feuille de stevia rebaudiana, Fruit d'acérola
Dosi raccomandate in Canada
| Popolazione | Età | Quantità per assunzione | Frequenza |
|---|---|---|---|
| Adultes | Non précisée | 1 Mesures | 1 Tous les jours |
Usi autorizzati in Canada
Provides antioxidants for the maintenance of good health. Provides live microorganisms that contribute to healthy gut flora. Helps to support liver function.
Testo originale in inglese.
Un uso autorizzato in Canada non è un’indicazione sulla salute autorizzata nell’Unione europea. Consulti il registro delle indicazioni sulla salute.
Avvertenze in Canada
Cautions and Warnings : For Adult use only. Consult a health care practitioner prior to use if you have any type of acute infection; have gastrointestinal lesions/ulcers, are taking anticoagulant agents, anti-inflammatory agents, other enzyme products or antibiotics or before having surgery; if you have allergy to latex or fruits (such as avocado, banana, chestnut, passion fruit, fig, melon, mango, kiwi, pineapple, peach and tomato); if you have nausea, fever, vomiting, bloody diarrhea or severe abdominal pain or if symptoms of digestive upset occur, worsen or persist beyond 3 days. Consult a health care practitioner prior to use if you have diabetes, a liver disorder or develop symptoms of liver trouble (such as abdominal pain, dark urine or jaundice); if you have an iron deficiency; if you have gallstones or a bile duct obstruction, stomach ulcers or excess stomach acid, or if symptoms persist or worsen; if you have a history of kidney stones; if you are taking cardiac glycosides such as digitalis/digoxin. Consumption with alcohol, other drugs or natural health products with sedative properties is not recommended.
Testo originale in inglese.
Contra-Indications : Do not use if you have high blood pressure; if you have liver or gall bladder disorders, and/or bowel obstruction; if you are pregnant or breastfeeding; if you have an immune-compromised condition (e.g. AIDS, lymphoma, patients undergoing long-term corticosteroid treatment); or if you are using health care products that affect blood coagulation (e.g. blood thinners, clotting factor replacements, acetylsalicylic acid, ibuprofen, fish oils Vitamin E) as these may increase the risk of spontaneous bleeding. Discontinue use if you develop symptoms of liver trouble. Do not use this product if you are attempting to conceive.
Testo originale in inglese.
Known Adverse Reactions : Hypersensitivity/allergy has been known to occur, in which case discontinue use. Nausea, vomiting, and diarrhea have been known to occur, in which case discontinue use and consult a health care practitioner. Laxative effect may occur, in which case discontinue use. This product has come into contact with dairy and soy proteins; if you have a gluten, milk or soy allergy, do not use this product.
Testo originale in inglese.
Scheda del prodotto
- Titolare
- FoodState Incorporated
- NPN o DIN-HM
- 80041613
- Stato
- Licenza non attiva
- Data della licenza
- 11 aprile 2013
- Data di revisione
- Non indicata
- Forma
- Poudre
- Via di somministrazione
- Orale
- Tipo di domanda
- Non traditionnelle
Fonte
Scheda ufficiale Health Canada, licenza 80041613
Banca dati dei prodotti naturali per la salute autorizzati (BDPSNH), Health Canada: prodotti autorizzati, ingredienti, dosi, usi e avvertenze, consultato il 27 ottobre 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Testo originale in inglese.
Testo originale in francese.
La formula venduta in Europa con lo stesso nome può essere diversa. Queste informazioni non sostituiscono il parere di un medico o farmacista.
Avvertenze ufficiali (Health Canada)
Health Canada pubblica avvertenze su questi ingredienti:
- Vaccinium macrocarpon
Leggere l'avvertenza, quando si applica e gli studi citati
Testo originale ufficiale in inglese.
CRANBERRY - VACCINIUM MACROCARPON
Via di somministrazione: Oral
Precauzioni e avvertenze
Condizione di applicazione: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a history of kidney stones (Gettman et al. 2005; Terris et al. 2001).
Fonti citate da Health Canada (2)
- Gettman MT, Ogan K, Brinkley LJ, Adams-Huet B, Pak CYC, Pearle MS. Effect of cranberry juice consumption on urinary stone risk factors. The Journal of Urology 2005;174(2):590-594. PubMed Studio randomizzato
- Terris MK, Issa MM, Tacker JR. Dietary supplementation with cranberry concentrate tablets may increase the risk of nephrolithiasis. Urology 2001;57(1):26-29. PubMed
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners (Brinker 2010; Aston et al. 2006; Rindone and Murphy 2005; Grant 2004).
Fonti citate da Health Canada (4)
- Aston JL, Lodolce AE, Shapiro NL. Interaction between warfarin and cranberry juice. Pharmacotherapy 2006;26(9):1314-1319. PubMed
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Grant P. Warfarin and cranberry juice: an interaction? The Journal of Heart Valve Disease 2004;13(1):25-26. PubMed Caso clinico
- Rindone JP, Murphy TW. Warfarin-cranberry juice interaction resulting in profound hypoprothrombinemia and bleeding. American Journal of Therapeutics 2005;13(3):283-284.
Condizione di applicazione: (Recurrent) urinary tract infection.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Monografia di Health Canada del 27 marzo 2026
DRIED CRANBERRY JUICE
Via di somministrazione: Oral
Precauzioni e avvertenze
Condizione di applicazione: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a history of kidney stones (Gettman et al. 2005; Terris et al. 2001).
Fonti citate da Health Canada (2)
- Gettman MT, Ogan K, Brinkley LJ, Adams-Huet B, Pak CYC, Pearle MS. Effect of cranberry juice consumption on urinary stone risk factors. The Journal of Urology 2005;174(2):590-594. PubMed Studio randomizzato
- Terris MK, Issa MM, Tacker JR. Dietary supplementation with cranberry concentrate tablets may increase the risk of nephrolithiasis. Urology 2001;57(1):26-29. PubMed
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners (Brinker 2010; Aston et al. 2006; Rindone and Murphy 2005; Grant 2004).
Fonti citate da Health Canada (4)
- Aston JL, Lodolce AE, Shapiro NL. Interaction between warfarin and cranberry juice. Pharmacotherapy 2006;26(9):1314-1319. PubMed
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Grant P. Warfarin and cranberry juice: an interaction? The Journal of Heart Valve Disease 2004;13(1):25-26. PubMed Caso clinico
- Rindone JP, Murphy TW. Warfarin-cranberry juice interaction resulting in profound hypoprothrombinemia and bleeding. American Journal of Therapeutics 2005;13(3):283-284.
Condizione di applicazione: (Recurrent) urinary tract infection.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
- Lécithine
Leggere l'avvertenza, quando si applica e gli studi citati
- Astragalus membranaceus
Leggere l'avvertenza, quando si applica e gli studi citati
Testo originale ufficiale in inglese.
ASTRAGALUS - ASTRAGALUS MEMBRANACEUS
Via di somministrazione: Oral
Precauzioni e avvertenze
Condizione di applicazione: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have an autoimmune disorder (Brinker 2010; Upton 1999).
Fonti citate da Health Canada (2)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Upton R, editor. American Herbal Pharmacopoeia and Therapeutic Compendium: Astragalus Root. Santa Cruz (CA): American Herbal Pharmacopoeia; 1999.
Controindicazioni
Condizione di applicazione: Traditional Chinese Medicine.
Do not use if you have exterior excess, stagnation, yin deficiency or excess heat (Bensky et al. 2004; Chen and Chen 2004).
Fonti citate da Health Canada (2)
- Bensky D, Clavey, Stöger E, Gamble A. Chinese Herbal Medicine: Materia Medica. 3rd edition. Seattle (WA): Eastland Press, Incorporated; 2004.
- Chen JK, Chen TT. Chinese Medical Herbology and Pharmacology. Crampton L, editor. City of Industry (CA): Art of Medicine Press Inc.; 2004.
- Vaccinium corymbosum
Leggere l'avvertenza, quando si applica e gli studi citati
Testo originale ufficiale in inglese.
Blueberry
Via di somministrazione: Oral
Precauzioni e avvertenze
Si applica ai prodotti: providing 5 grams or more of total dried fruit, per day; Products providing 37.5 grams or more of total fresh fruit, per day.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners (ASHP 2005; Franco et al. 2004; IOM 2001; Hansten et al. 1997).
Fonti citate da Health Canada (4)
- ASHP 2005: American Society of Health-System Pharmacists. American Hospital Formulary Service (AHFS) Drug Information. Philadelphia (PA): Lippincott Williams and Wilkins; 2005.
- Franco V, Polanczyk CA, Clausell N, Rohde LE. Role of dietary vitamin K intake in chronic oral anticoagulation: prospective evidence from observational and randomized protocols. The American Journal of Medicine 2004;166(10):651-656. PubMed Studio randomizzato
- Hansten PD, Horn JR, editors. Drug Interactions Analysis and Management. Vancouver (WA): Applied Therapeutics Inc.; 1997.
- IOM 2001: Institute of Medicine. Panel on Micronutrients, Subcommittees on Upper Reference Levels of Nutrients and Interpretation and Uses of Dietary Reference Intakes, and the Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, Food and Nutrition Board, Institute of Medicine. Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc. Washington (DC): National Academies Press; 2001.
- Withania somnifera
Leggere l'avvertenza, quando si applica e gli studi citati
Testo originale ufficiale in inglese.
ASHWAGANDHA - WITHANIA SOMNIFERA
Via di somministrazione: Oral
Precauzioni e avvertenze
Condizione di applicazione: General debility; Memory enhancement; Adaptogen; Restlessness/nervousness.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Condizione di applicazione: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Upton 2000; McGuffin et al. 1997).
Fonti citate da Health Canada (3)
- McGuffin M, Hobbs C, Upton R, Goldberg A, editors. American Herbal Products Association's Botanical Safety Handbook. Boca Raton (FL): CRC Press, LLC; 1997.
- Upton R, editor. American Herbal Pharmacopoeia and Therapeutic Compendium: Ashwagandha Root (Withania somnifera) - Standards of Analysis, Quality Control, and Therapeutics. Santa Cruz (CA): American Herbal Pharmacopoeia; 2000.
- Berardi RR, DeSimone EM, Newton GD, Oszko MA, Popovich NG, Rollins CJ, Shimp LA, Tietze K, éditeurs. Handbook of Nonprescription Drugs: An Interactive Approach to Self-Care, 13e édition. Washington (DC) : American Pharmaceutical Association; 2002.
When using this product exercise caution if you drive or use machinery as you may experience drowsiness (Berardi et al. 2002).
Fonti citate da Health Canada (3)
- Berardi RR, DeSimone EM, Newton GD, Oszko MA, Popovich NG, Rollins CJ, Shimp LA and Tietze KJ, editors. Handbook of Nonprescription Drugs: An Interactive Approach to Self-Care, 13th edition. Washington (DC): American Pharmaceutical Association; 2002.
- McGuffin M, Hobbs C, Upton R, Goldberg A, éditeurs. American Herbal Products Association's Botanical Safety Handbook. Boca Raton (FL) : CRC Press, LLC; 1997.
- Upton R, éditeur. Ashwagandha Root, Withania somnifera Analytical, Quality Control, And Therapeutic Monograph. Santa Cruz (CA) : American Herbal Pharmacopoeia and Therapeutic Compendium; 2000.
- Curcuma longa
Leggere l'avvertenza, quando si applica e gli studi citati
Testo originale ufficiale in inglese.
TURMERIC - CURCUMA LONGA - Oral
Via di somministrazione: Oral (ESCOP 2003; Blumenthal et al. 2000)
Precauzioni e avvertenze
Condizione di applicazione: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (ESCOP 2003; Brinker 2001; McGuffin et al. 1997).
Fonti citate da Health Canada (2)
- ESCOP: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (GB): European Scientific Cooperative on Phytotherapy and Thieme; 2003.
- McGuffin M, Hobbs C, Upton R, Goldberg A, editors. American Herbal Products Association's Botanical Safety Handbook. Boca Raton (FL): CRC Press; 1997.
1 studio citato nel testo non ha un riferimento corrispondente nella monografia (vedi le anomalie nella pagina delle fonti).
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a liver or biliary disorder (HC 2025; EMA 2018; Brinker 2010; ESCOP 2003; McGuffin et al. 1997).
Fonti citate da Health Canada (6)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- EMA 2018. European Medicines Agency. European Union herbal monograph on Curcuma longa L., rhizome. London (GB): EMA Committee on Herbal Medicinal Products (HMPC); 25 September 2018. [Accessed 2023 October 14] Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-curcuma-longa-l-rhizoma-revision-1_en.pdf
- ESCOP: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (GB): European Scientific Cooperative on Phytotherapy and Thieme; 2003.
- HC 2025: Health Canada: Summary Safety Review - Turmeric and Curcuminoids for Oral Use - Assessing the Potential Risk of Hepatotoxicity. Available from: https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR1758121117867
- McGuffin M, Hobbs C, Upton R, Goldberg A, editors. American Herbal Products Association's Botanical Safety Handbook. Boca Raton (FL): CRC Press; 1997.
- SC 2025: Santé Canada : Résumé de l'examen de l'innocuité - Curcuma et curcuminoïdes pour usage oral - Évaluation du risque potentiel d'hépatotoxicité. Disponible à : https://pmps.hpfb-dgpsa.ca/documents-d-examen/ressource/SSR1758121117867
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking medications (HC 2025).
Fonti citate da Health Canada (2)
- HC 2025: Health Canada: Summary Safety Review - Turmeric and Curcuminoids for Oral Use - Assessing the Potential Risk of Hepatotoxicity. Available from: https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR1758121117867
- SC 2025: Santé Canada : Résumé de l'examen de l'innocuité - Curcuma et curcuminoïdes pour usage oral - Évaluation du risque potentiel d'hépatotoxicité. Disponible à : https://pmps.hpfb-dgpsa.ca/documents-d-examen/ressource/SSR1758121117867
Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if you experience any new symptoms including yellowing of the eyes or skin, dark urine, nausea, vomiting, stomach pain (HC 2025).
Fonti citate da Health Canada (2)
- HC 2025: Health Canada: Summary Safety Review - Turmeric and Curcuminoids for Oral Use - Assessing the Potential Risk of Hepatotoxicity. Available from: https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR1758121117867
- SC 2025: Santé Canada : Résumé de l'examen de l'innocuité - Curcuma et curcuminoïdes pour usage oral - Évaluation du risque potentiel d'hépatotoxicité. Disponible à : https://pmps.hpfb-dgpsa.ca/documents-d-examen/ressource/SSR1758121117867
Condizione di applicazione: All uses except for Source of antioxidants and Hepatoprotectant.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Monografia di Health Canada del 26 settembre 2025
Turmeric -CURCUMA LONGA - Topical
Precauzioni e avvertenze
For external use only.
When using this product avoid contact with eyes. If contact occurs, rinse thoroughly with water.
Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen or last (for) more than 7 days.
Keep out of reach of children. If swallowed, call a poison control centre or get medical help right away.
Controindicazioni
Do not use on deep or puncture wounds, animal bites or serious burns.
Riguardano l'ingrediente, non questo prodotto né la sua dose. Non sostituiscono il parere medico.
La data della prova di questo elenco di ingredienti è sconosciuta.
Il prodotto è cambiato? Fotografi la confezione.
Un'informazione inesatta o più recente su questo prodotto, che lei sia lettore o marca? Scriva a contact@compoatlas.com: ogni correzione è pubblicata nel registro delle correzioni.